missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Mouse Integrin alpha 4 beta 7 Protein
Description
The Recombinant Mouse Integrin alpha 4 beta 7 Protein is derived from CHO. The Recombinant Mouse Integrin alpha 4 beta 7 Protein has been validated for the following applications: Bioactivity.
Specifications
Specifications
| For Use With (Application) | Bioactivity |
| Gene ID (Entrez) | 3676 |
| Molecular Weight (g/mol) | Observed M.W.: 115 - 170kDa, reducing conditions, Theoretical M.W.: 113kDa (Integrin alpha 4), 84kDa (Integrin beta 7) |
| Quantity | 50 μg |
| Source | Chinese Hamster Ovary cell line,CHO-derived mouse Integrin alpha 4 beta 7/LPAM-1 protein, (N-terminus) Mouse Integrin alpha 4 Tyr34-Gln970 (Arg591Leu) Accession &Num; AAH68313 GS Linker Acidic Tail HHHHHH Mouse Integrin ss7 Glu20-Arg724 Accession &Num; P26011 GS Linker Basic Tail (C-terminus) |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU per 1μg of the protein by the LAL method. |
| Gene Alias | 269C wild type, CD49 antigen-like family member D, CD49d, CD49d antigen, CD49d/beta7, CD49Dantigen CD49D, alpha-4 subunit of VLA-4 receptor, IA4, integrin alpha 4, integrin alpha-4, integrin alpha-4 subunit, Integrin alpha-IV, integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor), LPAM1, LPAM-1, MGC90518, very late activation protein 4 receptor, alpha 4 subunit, VLA-4 subunit alpha |
| Common Name | Integrin alpha 4 beta 7/LPAM-1 |
| Gene Symbol | Itga5 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?